Option Care Health reported second-quarter revenue of $1.44 billion, exceeding analyst estimates of $1.42 billion and marking a 1.9% year-on-year increase. Adjusted earnings per share came in at $0.45, a 5.4% beat over the consensus of $0.43, while adjusted EBITDA of $117.5 million also topped expectations. The company reconfirmed its full-year revenue guidance at $5.73 billion and slightly raised its adjusted EPS outlook to $1.89 at the midpoint. Management attributed the outperformance to high-single-digit organic growth in the acute therapy portfolio and stabilization in the chronic inflammatory disease segment, supported by cost controls and technology investments.
Option Care Health IncQ2 revenue and EPS beat estimates, with raised EPS guidance.